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Abstract
Background: The methodological quality and completeness of reporting of the systematic reviews (SRs) is
fundamental to optimal implementation of evidence-based health care and the reduction of research waste.
Methods exist to appraise SRs yet little is known about how they are used in SRs or where there are potential gaps
in research best-practice guidance materials.
The aims of this study are to identify reports assessing the methodological quality (MQ) and/or reporting quality
(RQ) of a cohort of SRs and to assess their number, general characteristics, and approaches to ‘quality’ assessment
over time.
Methods: The Cochrane Library, MEDLINE®, and EMBASE® were searched from January 1990 to October 16, 2014,
for reports assessing MQ and/or RQ of SRs. Title, abstract, and full-text screening of all reports were conducted
independently by two reviewers. Reports assessing the MQ and/or RQ of a cohort of ten or more SRs of
interventions were included. All results are reported as frequencies and percentages of reports.
Results: Of 20,765 unique records retrieved, 1189 of them were reviewed for full-text review, of which 76 reports
were included. Eight previously published approaches to assessing MQ or reporting guidelines used as proxy to
assess RQ were used in 80% (61/76) of identified reports. These included two reporting guidelines (PRISMA and
QUOROM) and five quality assessment tools (AMSTAR, R-AMSTAR, OQAQ, Mulrow, Sacks) and GRADE criteria. The
remaining 24% (18/76) of reports developed their own criteria. PRISMA, OQAQ, and AMSTAR were the most
commonly used published tools to assess MQ or RQ. In conjunction with other approaches, published tools were
used in 29% (22/76) of reports, with 36% (8/22) assessing adherence to both PRISMA and AMSTAR criteria and 26%
(6/22) using QUOROM and OQAQ.
Conclusions: The methods used to assess quality of SRs are diverse, and none has become universally accepted.
The most commonly used quality assessment tools are AMSTAR, OQAQ, and PRISMA. As new tools and guidelines
are developed to improve both the MQ and RQ of SRs, authors of methodological studies are encouraged to put
thoughtful consideration into the use of appropriate tools to assess quality and reporting.
Keywords: Reporting quality, Methodological quality, Systematic reviews, Guideline adherence
* Correspondence: dmoher@ohri.ca
10Centre for Journalology, Canadian EQUATOR Centre, Clinical Epidemiology
Program, Centre for Practice-Changing Research, Ottawa Hospital Research
Institute, Ottawa, Ontario, Canada
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Pussegoda et al. Systematic Reviews  (2017) 6:117 
DOI 10.1186/s13643-017-0507-6
Background
With the global annual expenditure of biomedical re-
search estimated to be in excess of 100 billion USD [1],
it is no surprise that the extent of published literature is
growing each year, with PubMed® housing over 24 mil-
lion citations, for example [2]. Researchers and decision
makers have recognized that although there are hun-
dreds of thousands of studies of healthcare interven-
tions, the quality of research and reporting is variable.
Evidence indicates that unless research is adequately de-
signed and reported, the resources invested in research
are not used effectively [1]. One estimate suggests that
at least 50% of published research studies were poorly
conducted making them difficult to interpret and use to
inform best practice [1].
Systematic reviews (SRs) are considered the gold
standard for healthcare decision-making as they evaluate
the quality and confidence of all of the available evidence
addressing specific questions, such as the benefits and
harms of specific health care interventions. When SR
conduct is optimal, that is, when best practices are
employed to minimize biases in the process of collecting,
appraising, and synthesizing the evidence, researchers
can best understand whether or not they can be
confident in the findings [3, 4]. Further, when SR report-
ing is optimal, the essential information is presented for
practice guideline developers and other stakeholders,
such as policy makers and clinicians to facilitate transla-
tion into guidance and improved patient care.
Criteria for assessing the quality of primary research
emerged in the late 1980s with the rise of evidence-
based medicine. This set the stage for guidelines asses-
sing quality of SR conduct to be developed. Several sets
of criteria had been developed early on including
Mulrow [5] and Sacks criteria [6]. It was not until
Oxman and Guyatt developed the Overview Quality As-
sessment Questionnaire (OQAQ) [7] in 1991, that a vali-
dated tool for assessing methodological quality (MQ)
existed for SRs of intervention studies. More than a dec-
ade after OQAQ, A Measurement Tool to Assess Sys-
tematic Reviews (AMSTAR) [8] was developed and
validated in 2007 to address additional SR quality criteria
including potential sources of bias that were not in-
cluded in the OQAQ tool. In 2010, AMSTAR was re-
vised (R-AMSTAR) to provide a quantitative scoring
method to assess quality [9]. With criteria available for
assessing SR conduct, it was apparent that SR authors
address the standards for improving reporting quality
(RQ) as well. In 1999, the Quality of Reporting of Meta-
analyses (QUOROM) statement [10] was created to evalu-
ate the completeness of reporting of meta-analysis of
randomized trials. Subsequently, in 2009, QUOROM was
updated as the Preferred Reporting Items of Systematic
reviews and Meta-Analyses (PRISMA) statement [11] to
address several conceptual and methodological advances
in the conduct and reporting of SRs. The development
and adoption of SR MQ and RQ tools aim to assess, and
hopefully improve, the design, conduct, and reporting of
SRs. Which tools are accepted and used by SR authors to
assess MQ and completeness of reporting was unclear.
We set out to identify methodological evaluations asses-
sing the MQ and/or RQ of SRs published from 1990 to
2014 in order to determine the approaches that were used.
Methods
Definitions and important concepts
We defined SRs and meta-analyses in line with that pro-
vided by the Cochrane Collaboration and the PRISMA
statement [12, 13]. We adopted the term ‘overview’, to
mean a summary of evidence from more than one SR, in-
cluding the combination of different populations, different
interventions, different outcomes (both favourable ones
and adverse events), or different conditions [14, 15]. It is
synonymous with ‘systematic review of systematic reviews’,
‘reviews of reviews’, or an ‘umbrella review’. We have in-
cluded publications of ‘methodological overviews’, meaning
research that has assessed the MQ and/or RQ of a cohort
of SRs and refer to these publications simply as ‘reports’.
Methodological quality and completeness of reporting
It is necessary to make clear the distinction between MQ
and RQ. MQ addresses how well a SR was designed and
conducted (e.g. literature search, selection criteria, pooling
of data) [8]. RQ evaluates the description of the method-
ology and findings [11]. Moreover, to distinguish from MQ,
the concept of risk of bias to assess primary studies is used
to refer to systematic flaws or limitations in the design, con-
duct, or analysis of research that distort the findings [16].
Examples are the Cochrane Risk of Bias tool for random-
ized controlled trials [17], ROBINS-I for non-randomized
studies [18], QUADAS-2 [19] for diagnostic studies, and
ROBIS for SRs [16]).
Objectives
The objectives of this study are to identify reports asses-
sing the MQ and/or RQ of SRs and to assess their general
characteristics and approaches used.
Eligibility criteria
Inclusion criteria
We included any methodological report published be-
tween January 1990 and October 2014 whose stated pri-
mary intent was to assess the quality of methodology,
reporting, or other self-identified quality indicator(s) of a
cohort of SRs of interventions.
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Exclusion criteria
We excluded reports of clinical interventions, whose pri-
mary intent was not to look at methodological quality or
reporting and rather to summarise SR evidence for use
in healthcare decision-making; reports assessing the
quality of SRs of diagnostic, screening, etiological, or
prognostic studies only; and evaluations of SRs that in-
clude study designs other than randomized controlled
trials such as, narrative reviews, rapid reviews, network
meta-analyses, and editorials. Reports in languages other
than English were excluded due to budget constraints
(Additional file 1) [20–31]. Reports assessing fewer than
10 SRs, those whose aim was to assess the reliability of
an assessment tool, those assessing SRs in relation to
one methodological characteristic (e.g. search strategy
only), or those only assessing SRs with pooled estimates
of effect, were also excluded.
Search methods
An experienced information specialist developed and con-
ducted an extensive search of the Cochrane Library,
EMBASE®, and Ovid MEDLINE®, including In-Process &
Other Non-Indexed Citations, from January 1990 to
May 23, 2012. All searches were updated on October
16, 2014. Potentially eligible titles and/or abstracts
were identified using a combination of subject headings
(e.g. ‘Meta-Analysis as Topic’, ‘Quality Control’, ‘Checklist’)
and key words (e.g. ‘umbrella review’, scoring, compliance)
(see Additional file 2). A second senior information spe-
cialist peer reviewed prior to execution [32]. Additional
reports eligible for inclusion were identified by members
of the research team prior to the start of the project and
used as ‘seed’ articles when developing the electronic
search strategy [33–35].
Screening
Titles and abstracts were screened for potentially inclusion
using a liberal accelerated approach (i.e. one reviewer to
include and two reviewers to exclude) [36]. Screening of
full-text reports was completed independently in duplicate
by a team of reviewers with experience in methodological
reviews; 5% of potentially relevant articles were pilot
tested. All screening disagreements were discussed, with
any outstanding disagreements resolved by an independ-
ent third reviewer (DM). Data Management software,
DistillerSR® [37], was used to manage retrieved records,
screen reports, identify and track disagreements, and store
data extracted. Results of the screening process are re-
ported using a PRISMA flow diagram (Fig. 1).
Data extraction
We developed standardized forms for data extraction of
items of interest from the included reports. General
characteristics and full data extraction was conducted by
two reviewers in duplicate; a 10% random sample of re-
ports was assessed for accuracy. A pre-extraction meet-
ing was held for each extraction stage along with pilot
testing to ensure consistency across reviewers. The fol-
lowing general characteristics were extracted: year of
publication; number of included SRs; specified medical
area; databases searched; language restrictions; SR defin-
ition; reporting of availability of study protocol; and
source of funding. The method of assessing MQ or RQ
of SRs was extracted. Additional items pertaining to the
evaluated reviews were extracted including the following:
types of publishing journals; Cochrane or non-Cochrane
review; conflict of interest; number of SRs reported as
updated reviews; number of SRs discussing limitations;
critical appraisal of abstracts; number of SRs reporting
meta-analysis; methods of meta-analysis used in the SRs
(e.g. methods used for meta-analysis and type of meas-
ure, details of investigation of publication bias, whether
or not heterogeneity was reported as assessed); whether
interpretation were consistent with results; and whether
a quantitative summary of quality was provided.
The attributes of primary of interest were to identify the
method or tool used to assess (a) MQ of SRs (e.g. use of
AMSTAR) and (b) RQ of SRs (e.g. use of PRISMA, identi-
fication of key methodological items). We classified tools/
criteria into two groups: (1) items obtained from existing,
published tools and (2) those developed by the report au-
thors for their assessment.
Adherence data in relation to the MQ and RQ criteria
were also extracted from those reports that provided it
and are reported in a separate manuscript [38].
Analyses
Summary statistics are reported as frequency and percent-
age of reports. No formal inferential statistical analyses
were conducted. A post hoc decision was made to look at
publications by their intent to assess MQ only, RQ only,
or both MQ and RQ. This decision was made in order to
identify all methods or tools used by overview authors to
assess methodological conduct or reporting. In addition,
we can identify whether the appropriate methods or tools
were used to assess MQ or RQ of SRs. Differences in SR
characteristics such as funding, limitations, and language
restrictions whose intent was to assess MQ or both MQ
and RQ can also be determined. This decision was made
without prior review of the data by one of us (DM).
Results
Of 20,765 unique title and abstract records retrieved and
screened, 1189 full-text reports were reviewed for
eligibility, of which 935 were excluded for not assessing
a cohort of SRs or the primary intent was not to assess
MQ or RQ. A secondary, full-text review of 254
remaining reports was carried out to ensure all exclusion
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criteria were met. A total of 76 reports were included
(Fig. 1; see Additional file 3).
Report characteristics
Characteristics of included reports are shown in Table 1.
Of the 76 included reports, 66% (50/76) of them had a
primary intent to assess MQ only, while the remaining
one-third had a primary intent to assess either both MQ
and RQ or RQ only; the latter two categories were
grouped together, post hoc, given six reports (8%)
assessed RQ only. Reports spanned a 21-year period; half
were published between 2010 and 2014, indicating a
marked increase in more recent years. A median of 51
SRs (interquartile range 25 to 105) were assessed in re-
ports. SRs assessed were published within a specific
medical field in 87% (66/76) of reports. Included SRs
were reported to be of interventions in medical fields
such as orthodontics, food and beverage, pediatrics,
nephrology, and dermatology; there were no predomin-
ant fields. SRs were mainly from a general sample of re-
views across medical journals; 7% (5/76) of reports
evaluated a cohort of Cochrane reviews only. The major-
ity of reports provided their source of SRs, whether via
database searches or specific journals. Forty-one percent
of reports did not report whether language restrictions
were used, whereas the remaining 59% were nearly
evenly divided as to whether they did or not. SR defined
for inclusion criteria were provided by nearly 30%, while
43% used ‘systematic review’ as a search term, and
26% did not report this information. Few reports
made reference to an available protocol. Thirty-nine
percent of reports did not report the source of finan-
cial support for their research.
Characteristics of SRs included in reports
Information reported by reports about included SRs is
shown in Table 2. More than half (44/76) of reports re-
ported information on the review’s source of funding, of
which most (35/44) did so as part of their tool assess-
ment. Conflict of interest information was reported in
45% (34/76) of reports in relation to a published tool as-
sessment, whereas three reports did so as a stand-alone
quality item. Heterogeneity assessment in reviews was
considered as a marker for ‘quality’ in 62% (47/76) of re-
ports, and 13% (10/76) reported this information as part
of a published tool. Forty-two percent of reports stated
Fig. 1 Flow of study reports
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how many of the included reviews had reported con-
ducting a meta-analysis. Seventeen percent (13/76) re-
ported which SRs were updates of an original review.
Half of the reports extracted whether or not reviews
considered issues of publication bias (formally or
informally). Limitations were described in half (14/26) of
the reports whose primary intent was to assess MQ and
RQ, whereas only 4% (2/50) reported this information in
reports whose intent was to assess MQ only. Critical ap-
praisal of SR abstracts was reported in 29% (22/76) of
Table 1 Table of characteristics of reports presented by methodological quality or both methodological and reporting quality
Characteristic Categorization Reports assessing
MQ only
Reports assessing MQ
and RQ or RQ only
All reports
N = 50, n (%) N = 26, n (%) N = 76, n (%)
Year of publication 1993–2009 26 (52) 11 (42) 37 (49)
2010–2014 23 (46) 16 (62) 39 (51)
Number of assessed SRs Median (IQR) 43 (21, 88) 68 (36, 109) 51 (25, 105)
Range 10–327 10–487 10–487
Were SRs of particular medical field? Yes 45 (90) 21 (81) 66 (87)
No 5 (10) 5 (19) 10 (13)
Cohort of Cochrane SRs Cochrane only 2 (4) 3 (12) 5 (7)
Sample of reviews 23 (46) 10 (38) 33 (43)
Specific journal sample or other 25 (50) 13 (50) 38 (50)
Number of databases searched 1 9 (18) 8 (31) 17 (22)
2 5 (10) 2 (8) 7 (9)
3 7 (14) 2 (8) 9 (12)
4 7 (14) 5 (19) 12 (16)
5 5 (10) 3 (12) 8 (11)
6 2 (4) 2 (8) 4 (5)
7 5 (10) 1 (4) 6 (8)
8+ 3 (6) 1 (4) 3 (4)
Not reported 4 (8) 0 (0) 4 (5)
Not applicable (select journals) 3 (6) 3 (12) 5 (7)
Reports restricting SRs by language No restrictions 14 (28) 6 (23) 20 (26)
Restricted to English 14 (28) 4 (15) 18 (24)
Restricted to English and another
specified languages
4 (8) 3 (12) 7 (9)
Not reported 18 (36) 13 (50) 31 (41)
SR defined for inclusion criteria? Yes, but no reference given 5 (10) 6 (23) 11 (15)
‘Systematic review’ reported as a
search term
21 (42) 12 (46) 33 (43)
Cochrane collaboration and PRISMA Statement 4 (8) 5 (19) 9 (12)
Other reference 3 (6) 0 (0) 3 (4)
Not reported 17 (34) 3 (12) 20 (26)
Was a study protocol reported as
available for this report?
Yes, link reported 1 (2) 2 (8) 3 (4)
Yes, upon request 6 (12) 2 (8) 8 (11)
No or not reported 43 (86) 22 (85) 65 (86)
Report Source of funding Industry Funded 2 (4) 0 (0) 2 (3)
Non-profit Funding 21 (42) 14 (54) 35 (46)
Reported no funding 6 (12) 3 (12) 9 (12)
Not reported 21 (42) 9 (35) 30 (39)
MQ methodological quality, RQ reporting quality
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reports, all of whose primary intent was to assess MQ
and RQ. Thirty-eight percent of reports (29/76) gave
consideration to how consistent review results were with
review conclusions. A quantitative summary of SR qual-
ity across items or criteria were provided in 59% (45/76)
of reports. The largest difference between reports with
the intent to assess MQ only and MQ and RQ is the
critical appraisal abstracts and limitations. This is likely
attributed directly to the structure of RQ guidelines (e.g.
PRISMA and QUOROM) specifically including report-
ing items for abstracts and limitations whereas MQ tools
(e.g. OQAQ and AMSTAR) do not (Table 2).
Use of published assessment tools to assess quality over
time
We assessed how frequently the published assessment
tools were used across reports, in 5-year increments
after 1999 (Fig. 2). For MQ, AMSTAR (27 reports) [8]
and OQAQ (26 reports) [7] were used the most often in
reports; others used R-AMSTAR (3 reports) [9], Mulrow
criteria (2 reports) [5], Grading of Recommendations
Assessment, Development, and Evaluation (GRADE) cri-
teria (2 reports) [39], and Sacks criteria (1 report) [6].
We observed that although OQAQ (1991) use for MQ
decreased after 2009, it was still being used despite the
Table 2 Information reported by reports about included SRs
Assessment of characteristics at the report level Reports assessing
MQ only
Reports assessing MQ
and RQ or RQ only
All reports
N = 50, n (%) N = 26, n (%) N = 76, n (%)
Source of funding 25 (50) 19 (73) 44 (58)
Conflict of interest 22 (44) 12 (46) 34 (45)
Heterogeneity investigated 32 (64) 15 (58) 47 (62)
Meta-analysis results reported 22 (44) 10 (38) 32 (42)
Updated reviews 6 (12) 7 (27) 13 (17)
Publication bias 25 (50) 13 (50) 38 (50)
Limitations discussed 2 (4) 14 (54) 16 (21)
Critically appraised abstracts 0 (0) 22 (85) 22 (29)
Interpretation consistent with results 21 (42) 8 (31) 29 (38)
Provided quantitative summary of quality or reporting
across reviews
29 (58) 16 (62) 45 (59)
MQ methodological quality, RQ reporting quality
Fig. 2 Tools or other criteria used by reports to assess SR quality or reporting over time
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availability of AMSTAR as of 2007 (10 [after 2010] vs.
16 [before 2010]). For RQ, PRISMA (13 reports) [11]
was used more often than its predecessor QUOROM (7
reports) [10]. No reports used QUOROM (1999) to
assess RQ after PRISMA (2009) guidelines were pub-
lished. In addition, several reports used their own cri-
teria to assess quality after 2000, although OQAQ (1991)
and QUOROM (1999) guidelines were available.
The above eight published tools were used across 80%
(61/76) of reports. These reports used those tools alone,
in combination with other tools or in combination with
self-specified criteria. The remaining 15 reports used
only self-specified criteria to assess quality.
Published assessment tools used alone or in combination
with other criteria to assess quality
Thirty-nine (51%) reports used published tools alone to
assess quality (Fig. 3). Mulrow, GRADE, and QUOROM
were used in one study each (1%; n = 76). AMSTAR and
OQAQ were used the most frequently as stand-alone
means to assess quality in 21% (16/76) and 20% (15/76)
of reports, respectively. PRISMA and R-AMSTAR were
used alone in three (4%; n = 76) and two (3%; n = 76) re-
ports, respectively.
In 29% (22/76) of reports, published tools or criteria
were used in conjunction with other criteria or tools to
assess MQ or RQ (Fig. 3). Of those assessing MQ and
RQ, 36% (8/22) used AMSTAR and PRISMA, 27% (6/
22) of reports used OQAQ and QUOROM, and 9% (2/
22) of reports used OQAQ and PRISMA. The remaining
reports used a variety of combinations: AMSTAR and R-
AMSTAR (5%; 1/22); OQAQ in conjunction with Sacks
criteria (5%; 1/22); AMSTAR and GRADE (5%; 1/22); a
published tool (OQAQ or Mulrow) in combination with
self-specified criteria (9%; 2/22); and AMSTAR in
conjunction with OQAQ and self-specified criteria (5%;
1/22). No reports evaluated a combined approach for
assessing RQ. Due to the number of different combina-
tions of tools and criteria used to assess quality in re-
ports, it was not conducive to separate by time as well.
Self-specified criteria to assess quality
Although OQAQ was published in 1991, authors devel-
oped their own criteria to assess MQ or RQ in 24% (18/
76) of reports. Of these reports, 15 only used self-specified
criteria to assess quality, and three reports used self-
specified criteria in combination with another tool (as de-
scribed above).
Quality assessment criteria used in these reports varied
considerably. Furthermore, 13 reports used their own
criteria to assess quality after the publication of both
OQAQ (1991) and QUOROM (1999). Seven of the 18
reports (39%) did not provide any description of how
they derived their quality assessment items. Of the
remaining 11 reports, the majority were derived from
the Oxman and Guyatt criteria. Two reports based cri-
teria on Oxman and Guyatt, Jadad Scale (developed to
assess primary studies), and QUOROM [40, 41]; one re-
port on Oxman and Guyatt and the Jadad Scale [42];
two reports on Oxman and Guyatt and Mulrow [43, 44];
Fig. 3 Published tools or self-specified criteria used alone or in conjunction presented by reported intent
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one report on Oxman and Guyatt, Light and Pillemer,
and Mulrow [45]; one report used Oxman Guyatt and
five additional criteria [46]; one report used Rapid
Appraisal Protocol (RAP), National Center for the Dis-
semination of Rehabilitation Research (NCDRR) [47];
one report was based on PRISMA [48]; one on PRISMA
and QUOROM [49]; and one report was based on
Oxman and Guyatt, Hoving scale, discussion between
three reviewers and expectations discussed from SRs by
Sackett and Seers [50].
Only four of the 18 reports (22%) provided an explan-
ation as to why they had created their own criteria. Two
reports stated criteria was developed to evaluate quality
of SRs in a specific medical field [40, 51]; one report
[44] published in 1996 stated there was no gold standard
for assessing quality; another report stated their quality
assessment scale was developed to specifically evaluate
patellofemoral pain syndrome [46].
Appropriate use of tools to assess quality of conduct vs.
reporting of conduct
We also assessed whether reports used the quality of meth-
odological conduct (MQ) and reporting (RQ) tools appro-
priately. The majority of reports used the tools correctly
(Fig. 3). However, we noted that several reports did not use
the tools or criteria appropriately based on their reported
or inferred intent. One report intended to assess both MQ
and RQ but only used OQAQ criteria, a tool for assessing
the quality of conduct. Another study intended to assess
both MQ and RQ but only used PRISMA, a reporting
guideline. Another report intended to assess RQ only and
used both OQAQ and QUOROM which are tools used to
assess quality of conduct and reporting of conduct. In
addition, one report used GRADE to assess MQ.
Discussion
We identified 76 reports in the health care literature
assessing the MQ and/or the RQ of SRs published in the
last 24 years in order to assess their quantity, characteris-
tics, and methodology over time. The number of such re-
ports increased over time with two-thirds intending to
assess MQ only and the remaining 34% assessing either
RQ only or both MQ and RQ. Although the number of re-
ports increased, the criteria used to assess MQ and critical
appraisal of SRs varied considerably across reports. Eight
published tools were used in 80% of reports while review
authors of the remaining reports only used their own cri-
teria to assess quality. We identified PRISMA, AMSTAR,
and OQAQ to be most commonly used tools.
This research parallels that of Dechartres et al. (2011),
who investigated how quality is assessed in RCTs [52].
Those authors found great variety in how the quality of
trials was assessed, from which the authors raised im-
portant issues about the tools and criteria that should be
used to assess RCT methodological quality and reporting
[53]. Although the diversity of assessment criteria and
the number of scales used to assess RCT quality was
greater, the authors found, as we did, that the number of
methodological reviews had increased over time.
Our findings appear consistent with that of other re-
search which suggests that tools used to assess MQ and
RQ of SRs are variable [33, 54, 55]. In 2012, two studies
were conducted to assess their methodological rigor
[56, 57]. The first concluded that PRISMA, OQAQ, and
AMSTAR were the most frequent methods of critical ap-
praisal and quality assessment for SRs and that inconsist-
ency in how SR quality is assessed should be reviewed
[56]. The second identified at least nine methods of asses-
sing SR quality and called for further empirical evidence
to support the conduct of overviews [57].
In addition, despite lack of available evidence, it would
be feasible to suggest that risk of bias assessment criteria
at the trial level over time may influence trial conduct.
By extension, critical appraisal criteria for SRs over time
may in turn influence SR conduct. A small body of lit-
erature has started to emerge with regard to biases
within SRs which would influence results of overviews
[58]. The SR community currently lacks clear guidance re-
garding best SR practices to minimize biases. Standardized
tools/criteria would provide the foundation upon which to
develop more consistent critical appraisal criteria for SRs,
which in turn could influence SR conduct.
Approximately 20% of methodological reports included
in our investigation did not report their intention to assess
either MQ or RQ in the title. This may be simply poor
reporting or may highlight the general confusion over
assessing SR ‘quality’ versus reporting of conduct. Quality
of conduct (MQ) tools were developed to assess how well
a SR was designed and conducted whereas reporting (RQ)
guidelines were designed to guide SR authors in appropri-
ate reporting of methodology and findings of SRs [8, 11].
The use of reporting guidance, such as PRISMA, to assess
the methodological conduct or quality of SRs is not appro-
priate. While PRISMA serves as a resource to improve the
quality of reporting of SRs, it is not an instrument to
gauge the quality of a SR [59]. By extension, we also argue
that the use of quality of conduct tools, such as OQAQ, to
assess quality of reporting of SRs is not appropriate. While
MQ criteria are important to improve quality of conduct,
they do not assess quality of reporting [8]. Moreover, we
also note that in one review, the authors inappropriately
used GRADE and items from the Jadad Scale to assess
MQ of SRs. GRADE was developed as a system for grad-
ing the quality of evidence of trials across studies for each
important outcome, while the Jadad Scale was developed
to assess the MQ/RQ of clinical trials assessing pain;
thus, applicability to SRs is questionable [35, 60]. SR
authors should adhere to MQ and RQ criteria to
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ensure high quality of conduct and accurate informa-
tion is reported in SRs.
Methodologists focus on improving quality and report-
ing, and new tools and guidelines continue to be devel-
oped. For example, the US Institute of Medicine
developed their own standards for assessing MQ in SRs
and reporting [61]. Further, Cochrane recommends
using the Methodological Expectations of Cochrane
Intervention Review (MECIR) to guide conduct of
Cochrane SRs for interventions [62]. Other recently
published tools to improve quality in SRs include the
Risk of Bias in Systematic Reviews (ROBIS) [16], devel-
oped to complement AMSTAR. The concept of risk of
bias is distinct from MQ in that it assesses systemic
flaws or limitations in the design, conduct, or analysis of
research that distort the findings [16]. Although there is
some content overlap between risk of bias and MQ cri-
teria, the majority of criteria are distinct. For example,
AMSTAR assesses whether at least two electronic
sources were searched whereas ROBIS assesses whether
the search included an appropriate range of databases
for published and unpublished reports. Nonetheless,
with the plethora of tools and guidance available,
there remains confusion over the best criteria and
tools to assess quality or reporting for consistent
standards across reports. This may be simply due to
SR authors being unaware of appropriate newer tools
that exist; or tools or guidelines that have less criteria
to assess are appealing simply due to lack of time; or
they feel some criteria are lacking in the validated
tools. Newer MQ and RQ tools such as AMSTAR
and PRISMA were developed to reflect of the state of
current SR methodology research. SR authors should
put thoughtful consideration into use of appropriate
MQ and RQ criteria to conduct their SR.
There are potential limitations to this study. All
methodological research relating to the quality of
studies, whether at the trial or SR level, is contingent
upon the quality of reporting. In addition, due to
feasibility, we have limited reports to English language
only, reports assessing more than 10 SRs and reports
using more than one methodology or reporting cri-
teria to assess quality.
Conclusions
In conclusion, a body of literature exists in evaluating
the quality and reporting of SRs across a variety of med-
ical fields. How quality is assessed varies and is similar
to the conclusions in other reports. As new tools and
guidelines are developed to improve both the MQ and
RQ of SRs, SR authors are encouraged to give careful
thought to the use of the most current and appropriate
tools to assess quality and reporting as they reflect the
state of current SR methodology research.
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